Results 121 to 130 of about 5,129,678 (250)

Biomethane Potential Test: Influence of Inoculum and the Digestion System [PDF]

, 2020
Benedikt Hülsemann, Lijun Zhou, Wolfgang Merkle, Julia Hassa, Joachim Müller, Hans Oechsner   +5 more
openalex   +1 more source

Permanent Deformation Monitoring and Remaining Life Prediction of Asphalt Pavement Combining Full-Scale Accelerated Pavement Testing and FEM [PDF]

, 2023
Zhen Liu, Xingyu Gu, Hua Ren, Shuwei Li, Qiao Dong   +4 more
openalex   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Testing theχc1pcomposite nature of the P c (4450)

, 2015
Ulf-G. Meißner, J. A. Oller
openalex   +1 more source

Testing the weak-form efficiency of the WTI crude oil futures market [PDF]

, 2014
Zhi‐Qiang Jiang, Wen-Jie Xie, Wei‐Xing Zhou   +2 more
openalex   +1 more source

Introducing and Implementing HIV Self-Testing in Côte d'Ivoire, Mali, and Senegal: What Can We Learn From ATLAS Project Activity Reports in the Context of the COVID-19 Crisis? [PDF]

, 2021
Arsène Kra Kouassi, Géraldine Colin, Papa Moussa Diop, Arlette Simo Fotso, Nicolas Rouveau, Kouakou Kouamé Hervé, Olivier Geoffroy, Bakary Diallo, Odé Kanku Kabemba, Baidy Dieng, Sanata Diallo, Anthony Vautier, Joseph Larmarange   +12 more
openalex   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa [PDF]

, 2019
Oliver J. Watson, Kelsey M. Sumner, Mark Janko, Varun Goel, Peter Winskill, Hannah Slater, Azra C. Ghani, Steven R. Meshnick, Jonathan B. Parr   +8 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

The Repetitive Saliva Swallowing Test (RSST) as a Screening Test of Functional Dysphagia. (2). Validity of RSST.

, 2000
Kazuyo Oguchi, Eiichi Saitoh, Mikoto Baba, Syoko KUSUDO, Tomomi Tanaka, Keiko Onogi   +5 more
openalex   +2 more sources